(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 10g

Ethyl 2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 95.0%, 5g

ethyl 8-(3,5-dichlorophenyl)-8-oxooctanoate, 97.0%, 1g

4-Bromopyridine-2,6-dicarboxylic acid, 95.0%, 100mg

N-Phenylthiourea>98.0%(HPLC)(N)500g

2-(4-Chloro-2-hydroxyphenoxy)acetic acid, 95.0%, 1g

Ethyl 2-((1r,4r)-4-((ethylamino)methyl)cyclohexyl)acetate, 98%, 250mg

trans 4-Isopropylcyclohexanecarboxylic acid, 98.0%, 25g

3-Bromo-1-methylpyridin-1-ium iodide, 1g

1-(Pyridin-4-yl)-1H-imidazole-5-carboxylic acid, 250mg

4,4,5,5-Tetramethyl-2-(3-methyl-4-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane, 95%, 5g

N-(Pyrimidin-5-yl)acetamide, 97%, 250mg

ethyl (2-hydroxyphenoxy)acetate, 95.0%, 25g